AbbVie Inc.
LEVODOPA AND CARBIDOPA INTESTINAL GEL AND METHODS OF USE

Abstract:

The present disclosure provides (a) a pharmaceutical composition comprising a levodopa active agent and a carbidopa active agent and (b) methods of treating Parkinson's disease and associated conditions comprising administering the pharmaceutical composition to a subject with Parkinson's disease.